The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 14, 2025

Filed:

Mar. 31, 2020
Applicant:

Obigen Pharma, Inc., Zhubei, TW;

Inventors:

Tzu-Wen Tsau, Taipei, TW;

Yung-Kai Wang, Taipei, TW;

Kuan-Cheng Shen, Taipei, TW;

Yueh-Chin Wu, Taipei, TW;

Cheng-Der Tony Yu, Taipei, TW;

Yu-Chun Tseng, Taipei, TW;

Assignee:

OBIGEN PHARMA, INC., Zhubei, CN;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/48 (2006.01); A61K 8/66 (2006.01); A61K 9/00 (2006.01); A61K 9/19 (2006.01); A61K 47/02 (2006.01); A61K 47/12 (2006.01); A61K 47/18 (2017.01); A61K 47/26 (2006.01); A61K 47/42 (2017.01); A61K 47/64 (2017.01); C07K 14/33 (2006.01); C12N 9/52 (2006.01);
U.S. Cl.
CPC ...
A61K 38/4893 (2013.01); A61K 8/66 (2013.01); A61K 9/0019 (2013.01); A61K 9/19 (2013.01); A61K 47/02 (2013.01); A61K 47/12 (2013.01); A61K 47/183 (2013.01); A61K 47/26 (2013.01); A61K 47/42 (2013.01); A61K 47/64 (2017.08); C07K 14/33 (2013.01); C12N 9/52 (2013.01); C12Y 304/24069 (2013.01);
Abstract

The present invention relates to a botulinum toxin type A complex, and a formulation thereof and a usage method therefor. The present invention provides the botulinum toxin type A complex, comprising an HA70 component, and an HA17 component, an HA33 component, an NINH component, and a BoNT/A1 component, wherein the botulinum toxin complex has a molecular weight of 740-790 kDa. Compared with the existing botulinum toxin complexes, the botulinum toxin complex of the present invention is smaller in molecular weight and higher in safety, and has a comparable treatment effect.


Find Patent Forward Citations

Loading…